Test Price
2,800 AED✅ Home Collection Available
MECP2 Gene (Autism Susceptibility, X-Linked Type 3) Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA-licensed clinicians.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143
Test Overview & Methodology
The MECP2 Genetic Test screens for mutations in the MECP2 gene associated with autism spectrum susceptibility, Rett syndrome, and X-linked intellectual disability type 3. Performed via next-generation sequencing, it delivers comprehensive analysis of the entire coding region, enabling precise clinical correlation and family planning.
| Feature | Our Test (MECP2 NGS) | Closest Alternative |
|---|---|---|
| Methodology | NGS Full Gene Sequencing | Targeted Mutation Panel (PCR) |
| Diagnostic Sensitivity | 99.9% (ISO 9001:2015 Validated) | ~85% (limited to known hotspots) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Pre‑Test Requirements: A detailed clinical history and a mandatory genetic counselling session to draw a pedigree chart of affected family members must be completed before sample collection.
Physician Insight & Safety Protocols
From Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403): “Pursuing genetic testing for autism susceptibility can understandably evoke strong emotions. This test offers vital molecular clarity, yet it is essential that results are interpreted within the full clinical picture by a qualified neurologist or clinical geneticist. Our team remains dedicated to supporting your family with empathy and expertise at every turn.”
Safety Advisory
⚠ Do not discontinue any prescribed medications or alter treatment plans without first consulting your doctor. Any changes must be evaluated in the context of genetic results and overall clinical assessment.
Exclusion Criteria
- Patients with severe bleeding disorders (e.g., haemophilia) require specialist clearance.
- Unstable medical conditions that could compromise safe blood collection.
- Inability to provide informed consent (or guardian consent for minors) in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Pregnant individuals should discuss test implications with their obstetrician.
Emergency Red Flags – Seek Immediate Medical Attention
- Sudden loss of speech or motor skills (regression).
- Breathing irregularities, apnea, or hyperventilation.
- Prolonged or new‑onset seizures.
- Severe lethargy or unresponsiveness.
Patient FAQ & Clinical Guidance
1. What is the MECP2 gene test and who should consider it?
This genetic test identifies mutations causing Rett syndrome and autism susceptibility in children with neurological signs. It is recommended for children presenting with developmental regression, loss of purposeful hand skills, speech delay, or atypical autism features, especially when a family history of X‑linked disorders is noted. A clinical geneticist or pediatric neurologist can best determine eligibility.
2. How is the test performed and what is the turnaround time?
A blood sample (EDTA whole blood) is collected via our mobile phlebotomy service or at our laboratory. The sample undergoes NGS full gene sequencing at our ISO‑accredited facility. Results are typically available within 3–4 weeks. A comprehensive report with clinical interpretation is provided.
3. Is genetic counseling required before testing?
Yes, a pre‑test genetic counseling session is mandatory to review family history and explain potential outcomes. UAE regulations (Federal Decree-Law No. 4 of 2016) and DHA guidelines require that all patients and guardians receive a dedicated counseling session. During this session, a certified genetic counselor will construct a pedigree, discuss the inheritance pattern, and outline the implications of possible results (pathogenic, benign, or variants of uncertain significance). This step empowers families to make informed decisions.
UAE Regulatory & Data Privacy Adherence
Your personal and genetic data are protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All laboratory processes comply with DHA standards for confidentiality, consent, and secure data handling.
Clinical & Logistical Metadata
| Test Name | MECP2 Gene (Autism Susceptibility, X-Linked Type 3) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral blood (EDTA whole blood) or extracted DNA |
| Methodology Used | NGS Full Gene Sequencing |
| ICD-10-CM Code | Z13.8 (Encounter for screening for other genetic and chromosomal anomalies) |
| LOINC Code | 21637-9 (MECP2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians